Organovo Holdings Inc (ONVO)
0.9881
-0.01
(-1.19%)
USD |
NASDAQ |
Apr 25, 16:00
0.9881
0.00 (0.00%)
After-Hours: 06:04
Organovo Holdings Enterprise Value: 4.626M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 4.626M |
| April 24, 2024 | 4.745M |
| April 23, 2024 | 4.745M |
| April 22, 2024 | 5.046M |
| April 19, 2024 | 5.749M |
| April 18, 2024 | 6.251M |
| April 17, 2024 | 5.950M |
| April 16, 2024 | 6.251M |
| April 15, 2024 | 8.259M |
| April 12, 2024 | 4.846M |
| April 11, 2024 | 5.047M |
| April 10, 2024 | 5.046M |
| April 09, 2024 | 5.226M |
| April 08, 2024 | 5.147M |
| April 05, 2024 | 4.946M |
| April 04, 2024 | 5.247M |
| April 03, 2024 | 5.047M |
| April 02, 2024 | 5.046M |
| April 01, 2024 | 5.046M |
| March 28, 2024 | 5.046M |
| March 27, 2024 | 4.846M |
| March 26, 2024 | 5.247M |
| March 25, 2024 | 5.046M |
| March 22, 2024 | 4.946M |
| March 21, 2024 | 5.046M |
| Date | Value |
|---|---|
| March 20, 2024 | 5.046M |
| March 19, 2024 | 5.247M |
| March 18, 2024 | 5.850M |
| March 15, 2024 | 5.247M |
| March 14, 2024 | 4.645M |
| March 13, 2024 | 4.846M |
| March 12, 2024 | 4.846M |
| March 11, 2024 | 4.846M |
| March 08, 2024 | 4.946M |
| March 07, 2024 | 4.846M |
| March 06, 2024 | 4.946M |
| March 05, 2024 | 5.046M |
| March 04, 2024 | 5.046M |
| March 01, 2024 | 4.946M |
| February 29, 2024 | 4.946M |
| February 28, 2024 | 4.846M |
| February 27, 2024 | 4.544M |
| February 26, 2024 | 4.604M |
| February 23, 2024 | 4.746M |
| February 22, 2024 | 4.846M |
| February 21, 2024 | 4.745M |
| February 20, 2024 | 5.035M |
| February 16, 2024 | 4.946M |
| February 15, 2024 | 4.946M |
| February 14, 2024 | 5.348M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-13.78M
Minimum
Jun 28 2022
135.61M
Maximum
Feb 11 2021
17.74M
Average
5.429M
Median
Jan 11 2024
Enterprise Value Benchmarks
| Marinus Pharmaceuticals Inc | 0.688M |
| Cartesian Therapeutics Inc | 294.69M |
| Adial Pharmaceuticals Inc | 4.188M |
| Longeveron Inc | -1.164M |
| Viracta Therapeutics Inc | 10.30M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.604M |
| Revenue (Quarterly) | 0.005M |
| Total Expenses (Quarterly) | 3.685M |
| EPS Diluted (Quarterly) | -0.40 |
| Profit Margin (Quarterly) | -72.08K% |
| Earnings Yield | -219.6% |
| Normalized Earnings Yield | -221.38 |